Estimation of screening test (Hemoccult®) sensitivity in colorectal cancer mass screening

3 controlled cohorts of mass-screening for colorectal cancer using a biennial faecal occult blood (HemoccultII®) test on well-defined European populations have demonstrated a 14% to 18% reduction in specific mortality. We aimed to estimate the sensitivity (S) of this HemoccultII®test and and also me...

Descripción completa

Detalles Bibliográficos
Autores principales: Jouve, J L, Remontet, L, Dancourt, V, Lejeune, C, Benhamiche, A M, Faivre, J, Esteve, J
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2001
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363664/
https://www.ncbi.nlm.nih.gov/pubmed/11384097
http://dx.doi.org/10.1054/bjoc.2001.1752

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363664/
https://www.ncbi.nlm.nih.gov/pubmed/11384097
http://dx.doi.org/10.1054/bjoc.2001.1752

Ejemplares similares